Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates that Thermo Fisher Scientific (TMO) receives a 66% rating based on their P/B Growth Investor model, which is based on the strategy of Partha Mohanram, signifying moderate interest in the stock. The model, which favors low book-to-market stocks with sustained growth characteristics, positively assesses TMO's book/market ratio, return on assets, cash flow from operations to assets, return on assets variance, and sales variance, but it flags the company's advertising, capital expenditures, and research and development relative to assets.

Analysis

Thermo Fisher Scientific Inc. (TMO) has received a 66% rating from Validea's P/B Growth Investor model, which is based on Partha Mohanram's strategy designed to identify low book-to-market stocks with characteristics of sustained future growth. This score indicates a moderate level of interest, falling below the 80% threshold typically signifying notable interest by this specific model. As a large-cap growth stock in the Medical Equipment & Supplies industry, TMO successfully met criteria related to its book/market ratio, return on assets, cash flow from operations to assets, the relationship between cash flow and return on assets, return on assets variance, and sales variance, suggesting solid current financial health and operational efficiency. However, the model flagged TMO for failing its tests on advertising to assets, capital expenditures to assets, and research and development to assets. For a company categorized under a growth profile, these specific failures related to investment and reinvestment metrics could raise questions about the drivers of long-term sustained growth, despite the positive performance on current profitability and cash flow measures.

Key Decisions for Investors

• Investors should consider the 66% P/B Growth Investor model score for TMO as a sign of only moderate alignment with this particular growth strategy, implying it may not represent a strong conviction 'buy' based solely on these specific model criteria.
• A deeper due diligence into why TMO's advertising, capital expenditures, and research and development ratios relative to assets are below the model's thresholds is recommended to assess potential impacts on its long-term growth trajectory.
• Holders of TMO may wish to monitor these flagged expenditure ratios in subsequent reporting periods to gauge whether the company is increasing investment in these key growth-driving areas or if the trend indicates potential future constraints.